Delving into the Latest Updates on Cord blood cell(StemCyte) with Synapse

Overview

Basic Info

Drug Type

Cell therapy

Synonyms-

Target-

Mechanism

Cell replacements

Therapeutic Areas

Nervous System DiseasesOther Diseases

Active Indication-

Inactive Indication

acute spinal cord injury

Originator Organization

StemCyte, Inc.

Active Organization-

Inactive Organization

StemCyte, Inc.

Drug Highest PhasePendingPhase 1/2

First Approval Date-

Regulation-

Login to view timeline

Wrinkle-improving effect of an all-in-one gel containing "Immortalized Human Tooth Pulp Stem Cell Conditioned Media" and "Human Cord Blood Stem Cell Conditioned Media" : single blinded study - Wrinkle-improving effect of an all-in-one gel containing "Immortalized Human Tooth Pulp Stem Cell Conditioned Media" and "Human Cord Blood Stem Cell Conditioned Media"

Start Date04 Apr 2023

Sponsor / Collaborator-

NCT01471613

/ CompletedPhase 1/2IIT

Safety and Effect of Lithium, Umbilical Cord Blood Cells and the Combination in the Treatment of Acute and Sub-acute Spinal Cord Injury : a Randomized, Double-Blinded Placebo-Controlled Clinical Trial

The trial is to investigate the safety and efficacy of oral lithium, intraspinal umbilical cord blood mononuclear cell transplant, and the combination in the treatment of acute and subacute spinal cord injury

Start Date01 Sep 2011

Sponsor / Collaborator

StemCyte, Inc.

100 Clinical Results associated with Cord blood cell(StemCyte)

Login to view more data

100 Translational Medicine associated with Cord blood cell(StemCyte)

Login to view more data

100 Patents (Medical) associated with Cord blood cell(StemCyte)

Login to view more data

100 Deals associated with Cord blood cell(StemCyte)

Login to view more data